Denise has over 25 years experience in the biopharmaceutical industry, in R&D management and as a VC. In 1999 she joined Nomura and became MD after heading the life science investment team investing globally in biotech companies. She led the Phase4 Partners MBO from Nomura in 2010. Denise has served on many US and European private and public boards, including Idenix (until acquired by Merck for $3.85bn).
Fiona was Founder & CSO of Heptares,a clinical-stage company creating novel medicines targeting G protein-coupled receptors (GPCRs), a superfamily of receptors linked to a wide range of human diseases. Heptares was acquired by Japanese biopharmaceutical giant Sosei Group in a $400m deal in 2015.
Melanie was Founding CEO and now NED of NightstaRx, a Syncona backed private biopharmaceutical company specialised in bringing sight improving treatments to patients with retinal dystrophies. Melanie is currently CSO of BTG plc, a fast growing Interventional Medicine company on the international stage with its HQ in London.
Vishal is one of Europe’s leading digital healthcare investors. A Partner at Draper Esprit, one of the largest and most active VC firms in Europe, Vishal is a qualified physician and chairman of the Digital Health Forum. Over the last decade he has championed deals across areas including diagnostics, devices & biotech.
An experienced entrepreneur, physician and business leader, Richard works to catalyse early innovations and discover opportunities for collaboration and investment across Johnson & Johnson’s global healthcare businesses. Prior to joining J&J Innovation, Richard was CEO at XO1 before the company was acquired in a J&J Innovation facilitated deal in 2015.
Peter is Co-founder of LayerWise, an innovative & award winning spin-out from the University of Leuven, active in metal Additive Manufacturing for industrial, dental and medical applications. Peter grew the company as MD to acquisition by 3D Systems Corporation in 2014.
Cathy is Mentor to the Ignite Summer Business School Programme at the Centre for Entrepreneurial Learning (University of Cambridge); Senior Associate for the Masters in Bioscience Enterprise (University of Cambridge) & Visiting Professor at Kings College, London. Previously, Cathy chaired the UK National Stem Cell Network Advisory committee.
Molecular biologist Wolf Reik is honorary Professor of Epigenetics at the University of Cambridge and Associate Faculty at the Wellcome Trust Sanger Institute, where he is a founding member of the Centre for Single Cell Genomics. He is a Fellow of the Academy of Medical Sciences and Fellow of the Royal Society.
For a recent article, we spoke to 5 CFOs who have spearheaded growth in a variety of market-leading tech companies, including Tim Score of ARM, about the role of the CFO.
Bailey Fisher is delighted to have sponsored the inaugural Techpreneurs Awards celebrating the achievements of female entrepreneurs in the technology sector.